BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raqib R, Ljungdahl A, Lindberg AA, Andersson U, Andersson J. Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection. Gut 1996;38:328-36. [PMID: 8675083 DOI: 10.1136/gut.38.3.328] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Chen S, Lin C, Tsai J, Chao Y, Sheu J. The Significance of Serum and Fecal Levels of Interleukin-6 and Interleukin-8 in Hospitalized Children with Acute Rotavirus and Norovirus Gastroenteritis. Pediatrics & Neonatology 2014;55:120-6. [DOI: 10.1016/j.pedneo.2013.05.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
2 Isabel Fernandez M, Sansonetti PJ. Effector Molecules of Shigella Pathogenesis and Host Responses. In: Hecht GA, editor. Microbial Pathogenesis and the Intestinal Epithelial Cell. Washington: ASM Press; 2003. pp. 455-79. [DOI: 10.1128/9781555817848.ch25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 2007;5:540-53. [PMID: 17558427 DOI: 10.1038/nrmicro1662] [Cited by in Crossref: 235] [Cited by in F6Publishing: 207] [Article Influence: 15.7] [Reference Citation Analysis]
4 Davis CL, Wahid R, Toapanta FR, Simon JK, Sztein MB. A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. PLoS One 2018;13:e0189571. [PMID: 29304144 DOI: 10.1371/journal.pone.0189571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis. J Clin Pathol 1997;50:513-20. [PMID: 9378821 DOI: 10.1136/jcp.50.6.513] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
6 Loré K, Spetz A, Fehniger TE, Sönnerborg A, Landay AL, Andersson J. Quantitative single cell methods that identify cytokine and chemokine expression in dendritic cells. Journal of Immunological Methods 2001;249:207-22. [DOI: 10.1016/s0022-1759(01)00293-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Fernandez MI, Sansonetti PJ. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis. International Journal of Medical Microbiology 2003;293:55-67. [DOI: 10.1078/1438-4221-00244] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
8 Samandari T, Kotloff KL, Losonsky GA, Picking WD, Sansonetti PJ, Levine MM, Sztein MB. Production of IFN-γ and IL-10 to Shigella Invasins by Mononuclear Cells from Volunteers Orally Inoculated with a Shiga Toxin-Deleted Shigella dysenteriae Type 1 Strain. J Immunol 2000;164:2221-32. [DOI: 10.4049/jimmunol.164.4.2221] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.1] [Reference Citation Analysis]
9 Raqib R, Ljungdahl Å, Lindberg AA, Wretlind B, Andersson U, Andersson J. Dissociation between cytokine mRNA expression and protein production in shigellosis. Eur J Immunol 1996;26:1130-8. [DOI: 10.1002/eji.1830260526] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
10 Enocksson A, Lundberg J, Weitzberg E, Norrby-Teglund A, Svenungsson B. Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis. Clin Diagn Lab Immunol 2004;11:250-4. [PMID: 15013971 DOI: 10.1128/cdli.11.2.250-254.2004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
11 Way SS, Borczuk AC, Dominitz R, Goldberg MB. An Essential Role for Gamma Interferon in Innate Resistance to Shigella flexneri Infection. Infect Immun 1998;66:1342-8. [DOI: 10.1128/iai.66.4.1342-1348.1998] [Cited by in Crossref: 70] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
12 Raqib R, Gustafsson A, Andersson J, Bakhiet M. A systemic downregulation of gamma interferon production is associated with acute shigellosis. Infect Immun 1997;65:5338-41. [DOI: 10.1128/iai.65.12.5338-5341.1997] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
13 Lee MS, Kim MH, Tesh VL. Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells. J Microbiol 2013;51:724-30. [PMID: 24385347 DOI: 10.1007/s12275-013-3429-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
14 Davis CL, Wahid R, Toapanta FR, Simon JK, Sztein MB, Levy D. Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics. PLoS One 2013;8:e59465. [PMID: 23589755 DOI: 10.1371/journal.pone.0059465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
15 Peng​ W, Lu D, Li G, Zhang X, Yao M, Zhang Y, Lin H. Two distinct interferon-γ genes in Tetraodon nigroviridis : Functional analysis during Vibrio parahaemolyticus infection. Molecular Immunology 2016;70:34-46. [DOI: 10.1016/j.molimm.2015.12.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
16 Mani S, Toapanta FR, McArthur MA, Qadri F, Svennerholm AM, Devriendt B, Phalipon A, Cohen D, Sztein MB. Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development. Vaccine 2019;37:4787-93. [PMID: 31230883 DOI: 10.1016/j.vaccine.2019.03.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet 2018;391:801-12. [PMID: 29254859 DOI: 10.1016/S0140-6736(17)33296-8] [Cited by in Crossref: 167] [Cited by in F6Publishing: 96] [Article Influence: 33.4] [Reference Citation Analysis]
18 Pasetti MF, Simon JK, Sztein MB, Levine MM. Immunology of gut mucosal vaccines. Immunol Rev 2011;239:125-48. [PMID: 21198669 DOI: 10.1111/j.1600-065X.2010.00970.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 83] [Article Influence: 15.0] [Reference Citation Analysis]
19 Wahid R, Simon JK, Picking WL, Kotloff KL, Levine MM, Sztein MB. Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. Clin Immunol 2013;148:35-43. [PMID: 23649043 DOI: 10.1016/j.clim.2013.03.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kokuba H, Aurelian L, Burnett J. Herpes Simplex Virus Associated Erythema Multiforme (HAEM) is Mechanistically Distinct from Drug-Induced Erythema Multiforme: Interferon-γ is Expressed in HAEM Lesions and Tumor Necrosis Factor-α in Drug-Induced Erythema Multiforme Lesions. Journal of Investigative Dermatology 1999;113:808-15. [DOI: 10.1046/j.1523-1747.1999.00754.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]
21 Perez-machado MA, Ashwood P, Torrente F, Salvestrini C, Sim R, Thomson MA, Walker-smith JA, Murch SH. Spontaneous TH1 cytokine production by intraepithelial but not circulating T cells in infants with or without food allergies. Allergy 2004;59:346-53. [DOI: 10.1046/j.1398-9995.2003.00328.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
22 Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect Immun 1997;65:739-49. [PMID: 9009337 DOI: 10.1128/iai.65.2.739-749.1997] [Cited by in Crossref: 75] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
23 Phalipon A, Sansonetti PJ. Shigella’ s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol 2007;85:119-29. [DOI: 10.1038/sj.icb7100025] [Cited by in Crossref: 161] [Cited by in F6Publishing: 142] [Article Influence: 10.7] [Reference Citation Analysis]
24 Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes. J Immunol 2014;192:1630-40. [PMID: 24453241 DOI: 10.4049/jimmunol.1302743] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
25 Heine SJ, Diaz-mcnair J, Martinez-becerra FJ, Choudhari SP, Clements JD, Picking WL, Pasetti MF. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD. Vaccine 2013;31:2919-29. [DOI: 10.1016/j.vaccine.2013.04.045] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
26 Chitradevi ST, Kaur G, Uppalapati S, Yadav A, Singh D, Bansal A. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection. Cell Mol Immunol 2015;12:757-67. [PMID: 25640657 DOI: 10.1038/cmi.2014.86] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
27 Le-Barillec K, Magalhaes JG, Corcuff E, Thuizat A, Sansonetti PJ, Phalipon A, Di Santo JP. Roles for T and NK cells in the innate immune response to Shigella flexneri. J Immunol 2005;175:1735-40. [PMID: 16034114 DOI: 10.4049/jimmunol.175.3.1735] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
28 Bagchi AK, Sinha AK. Role of 57 kDa major antigenic component of Shigella dysenteriae outer membrane proteins in induction of major histocompatibility complex II-restricted T-cell response. Archives of Medical Research 2004;35:427-34. [DOI: 10.1016/j.arcmed.2004.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
29 Bagchi AK, Sinha AK, Adhikari R, Maiti P, Mukherjee J, Panda A, Saha DR. Selective Deletion of CD8+ Cells Upregulated by Caspases-1 via IL-18 in Mice Immunized with Major Outer Membrane Protein of Shigella dysenteriae 1 Following Infection. J Clin Immunol 2010;30:408-18. [DOI: 10.1007/s10875-009-9359-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Toapanta FR, Bernal PJ, Kotloff KL, Levine MM, Sztein MB. T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. J Transl Med 2018;16:61. [PMID: 29534721 DOI: 10.1186/s12967-018-1439-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]